BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Autoimmunity
,
Doxorubicin
,
rs7903146
,
ERBB2
,
nitric oxide metabolic process
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NKG2D
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
T Lymphocyte (CD8+) of peripheral blood
Atrioventricular node
Superior cervical ganglion
Natural killer cell of peripheral blood
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell …
MICB Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death.
The Role of the NKG2D in Vitiligo.
Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with…
NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
NKG2D CAR-NK & r/rAML
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
NKG2D CAR-NK & Ovarian Cancer
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ